Simultaneous Hadamard Editing of GABA and Glutathione

NIH RePORTER · NIH · R01 · $367,756 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Edited magnetic resonance spectroscopy allows the non-invasive detection of low-concentration metabolites within the brain, such as the inhibitory neurotransmitter GABA and the redox compound glutathione (GSH). The signals of such metabolites are often overlapped in the MR spectrum, but a tailored spectral editing experiment can selectively retrieve signals of interest. Such “edited” approaches generally focus on measuring a single metabolite (i.e. either GABA or GSH) in a single brain region; the main goal of this proposal is to develop Hadamard-edited experiments that detect GABA and GSH simultaneously, in a single acquisition. We will develop the Hadamard-encoded HERMES approach, and multi-voxel Hadamard editing, using the SHERPA and HERMES-SHERPA approaches. The resulting data acquisition, post- processing and analysis tools will be made available for dissemination to the clinical neuroscience and neuroimaging communities.

Key facts

NIH application ID
9896825
Project number
5R01EB023963-04
Recipient
JOHNS HOPKINS UNIVERSITY
Principal Investigator
Richard Anthony Edward Edden
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$367,756
Award type
5
Project period
2017-05-05 → 2021-09-29